4//SEC Filing
Tourangeau Greg 4
Accession 0000899243-23-004744
CIK 0001680581other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 4:15 PM ET
Size
5.4 KB
Accession
0000899243-23-004744
Insider Transaction Report
Form 4
Tourangeau Greg
Principal Accounting Officer
Transactions
- Award
Stock Option (right to buy)
2023-02-09+16,100→ 16,100 totalExercise: $12.59Exp: 2033-02-08→ Common Stock (16,100 underlying)
Footnotes (1)
- [F1]This option was granted on February 9, 2023 and is is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2023, subject to the reporting person's continued service on each such vesting date.
Documents
Issuer
Fulcrum Therapeutics, Inc.
CIK 0001680581
Entity typeother
Related Parties
1- filerCIK 0001916566
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 4:15 PM ET
- Size
- 5.4 KB